StreetInsider.com News Articles

Form 8-K Pharma-Bio Serv, Inc. For: Sep 14

Mon, 14 Sep 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260914/27059380.html

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026

Mon, 14 Sep 2026 17:20:00 -0400

DORADO, PR / ACCESS Newswire / September 14, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and nine months ended July 31, 2026 were approximately $2.3 million and $7.3 million, respectively, representing increases of approximately $0.4 million and $0.5 million compared to the same periods last year.

For the three and nine months ended July 31, 2026, the Company reported a net loss of $14 thousand and net income of approximately $252 thousand,

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026

Mon, 14 Sep 2026 17:20:00 -0400

For the three and nine months ended July 31, 2026, the Company reported a net loss of $14 thousand and net income of approximately $252 thousand,

Form 10-Q Pharma-Bio Serv, Inc. For: Jul 31

Mon, 14 Sep 2026 17:14:00 -0400

si-local-file:///var/storage/secattach/20260914/27059303.html

Form 4 Pharma-Bio Serv, Inc. For: Jun 09 Filed by: SPINDEL HOWARD

Wed, 22 Jul 2026 20:31:00 -0400

si-local-file:///var/storage/secattach/20260722/26802971.html

Form 4 Pharma-Bio Serv, Inc. For: Jun 09 Filed by: SPINDEL HOWARD

Wed, 22 Jul 2026 20:31:00 -0400

si-local-file:///var/storage/secattach/20260722/26802971.html

Form 8-K Pharma-Bio Serv, Inc. For: Jun 15

Mon, 15 Jun 2026 17:06:00 -0400

si-local-file:///var/storage/secattach/20260615/26648462.html

Form 8-K Pharma-Bio Serv, Inc. For: Jun 15

Mon, 15 Jun 2026 17:06:00 -0400

si-local-file:///var/storage/secattach/20260615/26648462.html

Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026

Mon, 15 Jun 2026 17:00:00 -0400

DORADO, PR / ACCESS Newswire / June 15, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and six months ended April 30, 2026 were approximately $2.7 million and $5.0 million, respectively, representing increases of approximately $0.3 million and $0.1 million compared to the same periods last year.

Net income for the three and six months ended April 30, 2026, was approximately $0.2 million and $0.3 million, respectively, representing increases of approximately $0.1 million

Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026

Mon, 15 Jun 2026 17:00:00 -0400

Net income for the three and six months ended April 30, 2026, was approximately $0.2 million and $0.3 million, respectively, representing increases of approximately $0.1 million

Form 10-Q Pharma-Bio Serv, Inc. For: Apr 30

Mon, 15 Jun 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260615/26648182.html

Form 10-Q Pharma-Bio Serv, Inc. For: Apr 30

Mon, 15 Jun 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260615/26648182.html

Form 8-K Pharma-Bio Serv, Inc. For: May 15

Fri, 15 May 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260515/26507556.html

Form 8-K Pharma-Bio Serv, Inc. For: May 15

Fri, 15 May 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260515/26507556.html

Form ARS Pharma-Bio Serv, Inc. For: Oct 31

Thu, 16 Apr 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260416/26325305.html

Form ARS Pharma-Bio Serv, Inc. For: Oct 31

Thu, 16 Apr 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260416/26325305.html

Form DEF 14A Pharma-Bio Serv, Inc. For: Apr 15

Thu, 16 Apr 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260416/26325231.html

Form DEF 14A Pharma-Bio Serv, Inc. For: Apr 15

Thu, 16 Apr 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260416/26325231.html

Form 8-K Pharma-Bio Serv, Inc. For: Mar 17

Tue, 17 Mar 2026 17:19:00 -0400

si-local-file:///var/storage/secattach/20260317/26176596.html

Form 8-K Pharma-Bio Serv, Inc. For: Mar 17

Tue, 17 Mar 2026 17:19:00 -0400

si-local-file:///var/storage/secattach/20260317/26176596.html

Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026

Tue, 17 Mar 2026 17:05:00 -0400

DORADO, PUERTO RICO / ACCESS Newswire / March 17, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the quarter ended January 31, 2026 were approximately $2.3 million, a decrease of approximately $0.2 million when compared to the same period last year. Net income for the quarter ended January 31, 2026 was $32,860, an improvement of $24,324 when compared

Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026

Tue, 17 Mar 2026 17:05:00 -0400

Form 10-Q Pharma-Bio Serv, Inc. For: Jan 31

Tue, 17 Mar 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260317/26176262.html

Form 10-Q Pharma-Bio Serv, Inc. For: Jan 31

Tue, 17 Mar 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260317/26176262.html

Form 10-K/A Pharma-Bio Serv, Inc. For: Oct 31

Fri, 27 Feb 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260227/26082213.html